| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Apellis Pharmaceuticals, Inc. (APLS) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. APLS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.18M | $48.30M | - | |
| CEO | 482.0K | $19.78M | - | |
| Dir | 385.0K | $15.80M | - | |
| Dir | 161.6K | $6.63M | - | |
| CFO | 152.0K | $6.24M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 23, 2023 | Lewis Karen76 | Chief People Officer | Sell | 2,955 | $51.58 | $152,418.90 | -7.3% | +75.4% | +30.8% | |
| Jan 23, 2023 | Eisele Jeffrey76 | Chief Development Officer | Sell | 4,479 | $51.58 | $231,026.82 | -8.6% | +75.4% | +30.8% | |
| Jan 17, 2023 | MacHiels Alec57 | Director | Sale+OE | 1,250 | $52.42 | $65,525.00 | -0.5% | +57.8% | +26.7% | |
| Jan 9, 2023 | Deschatelets Pascal69 | Chief Scientific Officer | Sale+OE | 12,000 | $46.08 | $552,960.00 | -1.2% | +65.5% | +52.0% | |
| Jan 5, 2023 | Grossi Federico53 | Chief Medical Officer | Sell | 2,500 | $48.79 | $121,975.00 | -2.6% | +62.6% | +25.3% | |
| Jan 3, 2023 | Townsend Adam J.74 | Chief Commercial Officer | Sale+OE | 5,000 | $50.70 | $253,500.00 | -10.4% | +52.5% | +19.3% | |
| Jan 3, 2023 | Dunlop A. Sinclair62 | Director | Sell | 500 | $50.70 | $25,350.00 | -0.4% | +52.5% | +19.3% | |
| Dec 19, 2022 | Francois Cedric78 | Chief Executive Officer | Sale+OE | 28,200 | $52.06 | $1,467,983.31 | -1.4% | +21.1% | +11.4% | |
| Dec 15, 2022 | MacHiels Alec57 | Director | Sale+OE | 1,250 | $52.35 | $65,437.50 | -0.5% | +25.0% | +0.5% | |
| Dec 8, 2022 | Deschatelets Pascal69 | Chief Scientific Officer | Sale+OE | 12,000 | $47.50 | $570,000.00 | -1.2% | +28.6% | +24.6% |